KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Cash from Financing Activities (2016 - 2025)

Evolent Health has reported Cash from Financing Activities over the past 11 years, most recently at -$93.0 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$93.0 million for Q4 2025, down 195.97% from a year ago — trailing twelve months through Dec 2025 was -$35.9 million (down 6258.23% YoY), and the annual figure for FY2025 was -$35.9 million, down 6258.23%.
  • Cash from Financing Activities for Q4 2025 was -$93.0 million at Evolent Health, down from -$41.8 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for EVH hit a ceiling of $379.7 million in Q1 2023 and a floor of -$103.4 million in Q2 2024.
  • Median Cash from Financing Activities over the past 5 years was -$9.0 million (2024), compared with a mean of $17.3 million.
  • Biggest five-year swings in Cash from Financing Activities: surged 26901.72% in 2022 and later plummeted 677.15% in 2023.
  • Evolent Health's Cash from Financing Activities stood at $60.9 million in 2021, then crashed by 117.82% to -$10.9 million in 2022, then plummeted by 677.15% to -$84.4 million in 2023, then surged by 214.93% to $96.9 million in 2024, then tumbled by 195.97% to -$93.0 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$93.0 million (Q4 2025), -$41.8 million (Q3 2025), and -$8.9 million (Q2 2025) per Business Quant data.